NeuroPace reports record Q1 revenue $22.5M (+24% YoY), raises FY2025 guidance to $93-97M

NeuroPace Inc

2025-Q1 EPS reported -$0.21 revenue$22,524,000

Record quarterly revenue $22.5M, up 24% YoY; RNS System revenue up 29% excluding NAUTILUS study implants.
Gross margin 77.0% exceeded full-year guidance of 73-75%; operating loss narrowed to $5.1M from $7.5M.
Full-year 2025 revenue guidance raised to $93-97M (16-21% growth); expects NAUTILUS topline data in H2 2025.
Strategic refocus on core RNS System; terminating SEEG distribution relationship starting Q4 2025 through Q1 2026.
Cash and investments $66.3M; long-term debt $59.8M as of March 31, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.